Instil Bio Stock In The News

TIL Stock  USD 19.88  0.82  4.30%   
Our overall analysis of Instil Bio's news coverage and content from conventional and social sources shows investors' bearish mood towards Instil Bio. The specific impact of Instil Bio news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Instil Bio's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Instil Bio headlines in addition to utilizing other, more conventional financial analysis modules. Check out Instil Bio Backtesting and Instil Bio Hype Analysis.
For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.

Instil Bio Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Instil Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
https://www.globenewswire.com/news-release/2025/03/04/3036357/0/en/Instil-Bio-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Provides-Corporate-Update.html
 Neutral
Yahoo News
2 Stocks Up Over 700% in 2024 That Could Soar Even Further
https://finance.yahoo.com/news/2-stocks-over-700-2024-085600715.html
 Neutral
Yahoo News
Here's Why Everyone's Talking About Summit Therapeutics
https://finance.yahoo.com/news/heres-why-everyones-talking-summit-082400897.html
 Neutral
Macroaxis News: globenewswire.com
Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
https://www.globenewswire.com/news-release/2023/11/13/2779567/0/en/Instil-Bio-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
 Neutral
Macroaxis News: globenewswire.com
Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual Meeting
https://www.globenewswire.com/news-release/2023/11/06/2773915/0/en/Instil-Bio-Announces-Poster-Presentations-of-ITIL-306-Preclinical-Data-at-SITC-2023-Annual-Meeting.html
 Neutral
Macroaxis News: globenewswire.com
Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
https://www.globenewswire.com/news-release/2023/08/14/2724234/0/en/Instil-Bio-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
 Neutral
Yahoo News
CPMG Inc Acquires Significant Stake in Reata Pharmaceuticals Inc
https://finance.yahoo.com/news/cpmg-inc-acquires-significant-stake-030306844.html
 Bullish
Macroaxis News: globenewswire.com
Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference
https://www.globenewswire.com/news-release/2023/06/26/2694857/0/en/Instil-Bio-Announces-Oral-Presentation-of-ITIL-306-Preclinical-Data-at-British-Society-for-Gene-and-Cell-Therapy-Annual-Conference.html
 Neutral
Macroaxis News: globenewswire.com
Instil Bio Reports First Quarter 2023 Financial Results and Provides Corporate Update
https://www.globenewswire.com/news-release/2023/05/11/2666544/0/en/Instil-Bio-Reports-First-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
 Neutral
Macroaxis News: globenewswire.com
Instil Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
https://www.globenewswire.com/news-release/2023/03/31/2638526/0/en/Instil-Bio-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update.html
 Neutral

Instil Bio Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Instil and other traded companies coverage with news coverage. We help investors stay connected with Instil headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Instil Stock performance. Please note that trading solely based on the Instil Bio hype is not for everyone as timely availability and quick action are needed to avoid losses.
Instil Bio's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Instil Bio investors visualize upcoming and past events in order to time the market based on Instil Bio noise-free hype analysis.
Instil Bio stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Instil earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Instil Bio that are available to investors today. That information is available publicly through Instil media outlets and privately through word of mouth or via Instil internal channels. However, regardless of the origin, that massive amount of Instil data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Instil Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Instil Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Instil Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Instil Bio alpha.

Instil Largest EPS Surprises

Earnings surprises can significantly impact Instil Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-08-14
2023-06-30-0.16-0.140.0212 
2022-05-16
2022-03-31-0.38-0.42-0.0410 
2022-08-12
2022-06-30-0.41-0.46-0.0512 
2022-03-07
2021-12-31-0.36-0.43-0.0719 
2021-08-12
2021-06-30-0.2-0.27-0.0735 
2021-05-13
2021-03-31-0.52-0.66-0.1426 
View All Earnings Estimates

Instil Bio Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Instil Bio Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Yahoo News
5th of March 2025
KSQ Therapeutics Appoints Kristen Hege, M.D., to its Board of Directors
at finance.yahoo.com 
Google News at Macroaxis
24th of February 2025
Instil Bio Time To Hop On The Summit Wave - Seeking Alpha
at news.google.com 
Macroaxis News
13th of February 2025
Acquisition by Gibson Neil W of 1500 shares of Instil Bio at 11.18 subject to Rule 16b-3
at MacroaxisInsider 
Macroaxis News: globenewswire.com
14th of January 2025
Instil Bio Announces Clinical Progress in China for IMM2510SYN-2510, a Clinical-Stage PD-L...
at globenewswire.com 
Google News at Macroaxis
7th of January 2025
Bullish Outlook On Instil Bios Investigational Cancer Drug Jefferies Sees Over 300 percent...
at news.google.com 
Yahoo News
18th of December 2024
Juncell Therapeutics Opens State-of-the-Art Facility for TIL Production
at finance.yahoo.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Instil Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Instil Bio's short interest history, or implied volatility extrapolated from Instil Bio options trading.
When determining whether Instil Bio is a strong investment it is important to analyze Instil Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instil Bio's future performance. For an informed investment choice regarding Instil Stock, refer to the following important reports:
Check out Instil Bio Backtesting and Instil Bio Hype Analysis.
For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instil Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.39)
Return On Assets
(0.13)
Return On Equity
(0.38)
The market value of Instil Bio is measured differently than its book value, which is the value of Instil that is recorded on the company's balance sheet. Investors also form their own opinion of Instil Bio's value that differs from its market value or its book value, called intrinsic value, which is Instil Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instil Bio's market value can be influenced by many factors that don't directly affect Instil Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.